[Drug-induced systemic lupus erythematosus].
D000293:Adolescent; D000368:Aged; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000974:Antibodies, Antinuclear; D000927:Anticonvulsants / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000276:immunology; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D011324:Primidone / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects; D011619:Psychotropic Drugs / Q000009:adverse effects; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D000974:Antibodies, Antinuclear; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D004364:Pharmaceutical Preparations; D011619:Psychotropic Drugs; D011324:Primidone; D011342:Procainamide
Medikamentös induzierter systemischer Lupus erythematodes.